Financial reports
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
10-K
2022 FY
Annual report
10 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
2 Mar 22
10-Q
2021 Q3
Quarterly report
4 Nov 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
10-Q
2021 Q1
Quarterly report
4 May 21
10-K
2020 FY
Annual report
25 Feb 21
Current reports
8-K
Termination of a Material Definitive Agreement
4 May 23
8-K
Departure of Directors or Certain Officers
30 Mar 23
8-K
Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights
27 Mar 23
8-K
Other Events
15 Mar 23
8-K
Regulation FD Disclosure
13 Mar 23
8-K
Proposed acquisition of and merger with Redx Pharma Plc ("Target") – Deed of Irrevocable Undertaking
23 Feb 23
8-K
Departure of Directors or Certain Officers
20 Jan 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 Jan 23
8-K
Entry into a Material Definitive Agreement
27 Dec 22
8-K
Departure of Directors or Certain Officers
20 Dec 22
Registration and prospectus
15-12G
Securities registration termination
15 May 23
25-NSE
Exchange delisting
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 23
POS AM
Prospectus update (post-effective amendment)
4 May 23
Proxies
DEFA14A
Additional proxy soliciting materials
15 Mar 23
DEFA14A
Additional proxy soliciting materials
23 Feb 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
26 Apr 21
DEF 14A
Definitive proxy
26 Apr 21
DEFA14A
Additional proxy soliciting materials
2 Jun 20
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
DEFA14A
Additional proxy soliciting materials
23 Apr 19
Other
EFFECT
Notice of effectiveness
5 May 23
EFFECT
Notice of effectiveness
5 May 23
UPLOAD
Letter from SEC
2 May 23
UPLOAD
Letter from SEC
1 May 23
UPLOAD
Letter from SEC
26 Apr 23
CORRESP
Correspondence with SEC
24 Apr 23
UPLOAD
Letter from SEC
21 Apr 23
UPLOAD
Letter from SEC
14 Apr 23
UPLOAD
Letter from SEC
14 Apr 23
UPLOAD
Letter from SEC
30 Mar 23
Ownership
SC 13G/A
Deep Track Capital, LP
14 Feb 24
SC 13G
Opaleye Management Inc.
9 Feb 24
SC 13G/A
Cowen Financial Products LLC
2 Feb 24
4
Change in insider ownership
5 May 23
4
KEVIN C TANG
5 May 23
3
Initial statement of insider ownership
5 May 23
SC 13D/A
TANG CAPITAL PARTNERS LP
5 May 23
4
Luisa Salter-Cid
4 May 23
4
Jigar Raythatha
4 May 23
4
RICHARD /CA/ MURRAY
4 May 23